《宫颈癌标准治疗选择》由会员分享，可在线阅读，更多相关《宫颈癌标准治疗选择（34页珍藏版）》请在金锄头文库上搜索。
1、7/31/2024Dr.Xiaohua Wu 1Standard Treatment Optionsfor Cervical Cancer FIGO: Staging classifications and clinical practice guidelines of Cervical cancerNational Cancer Institute M.D. Anderson Cancer CenterPractical Gynecologic Oncology 4th Edition7/31/2024Dr.Xiaohua Wu 2Cancers of the Female Reproduc
2、tive Tract:Worldwide Statistics11.1. Ferlay Ferlay et al.et al. GLOBOCAN 2000 IARC, WHO 2001 (www.dep.iarc.fr GLOBOCAN 2000 IARC, WHO 2001 (www.dep.iarc.fr) ) CancerCancerNew CasesNew CasesDeathsDeathsCervical470,000230,000Endometrial189,00045,000Ovarian192,000114,000USANorthern EuropeSouthern Europ
3、e23,80010,00010,20015,6007,2006,2007/31/2024Dr.Xiaohua Wu 31974-2000上海市居民妇科肿瘤发病率上海市肿瘤研究流行病研究室年报告7/31/2024Dr.Xiaohua Wu 47/31/2024Dr.Xiaohua Wu 57/31/2024Dr.Xiaohua Wu 6Treatment Option Overview nFive randomized phase III trials have shown an overall survival advantage for cisplatin-based therapy giv
4、en concurrently with radiation therapy,1-6 while 1 trial examining this regimen demonstrated no benefit.7nThe risk of death from cervical cancer was decreased by 30% to 50% by concurrent chemoradiation. nBased on these results, strong consideration should be given to the incorporation of concurrent
5、cisplatin- based chemotherapy with radiation therapy in women who require radiation therapy for treatment of cervical cancer.1-87/31/2024Dr.Xiaohua Wu 7Treatment Option OverviewnSurgery and radiation therapy are equally effective for early-stage small-volume disease.9 nYounger patients may benefit f
6、rom surgery in regard to ovarian preservation and avoidance of vaginal atrophy and stenosis. nPatterns of care studies clearly demonstrate the negative prognostic effect of increasing tumor volume. nTherefore, treatment may vary within each stage as currently defined by FIGO, and will depend on tumo
7、r bulk and spread pattern.10 7/31/2024Dr.Xiaohua Wu 8Treatment Option OverviewnTherapy of patients with cancer of the cervical stump is effective, yielding results comparable to those seen in patients with an intact uterus.11 nDuring pregnancy, no therapy is warranted for preinvasive lesions of the
8、cervix, including carcinoma in situ, although expert colposcopy is recommended to exclude invasive cancer. nTreatment of invasive cervical cancer during pregnancy depends on the stage of the cancer and gestational age at diagnosis.7/31/2024Dr.Xiaohua Wu 9宫颈癌分期:临床诊断分期临床诊断分期q有经验的医师、在麻醉下进行检查有经验的医师、在麻醉下
9、进行检查q后来的发现不能改变已经确定的期别后来的发现不能改变已经确定的期别q触诊、视诊、阴道镜、宫颈管诊刮术触诊、视诊、阴道镜、宫颈管诊刮术(ECC)、宫腔镜、膀胱镜、直、宫腔镜、膀胱镜、直肠镜、静脉尿路造影、以及骨骼和肺部肠镜、静脉尿路造影、以及骨骼和肺部x线检查线检查q膀胱和直肠怀疑病灶须经活检并有组织学证实膀胱和直肠怀疑病灶须经活检并有组织学证实q淋巴管造影、动脉造影、静脉造影、剖腹探查术、超声探查、淋巴管造影、动脉造影、静脉造影、剖腹探查术、超声探查、CT扫描和磁共振（扫描和磁共振（MRI）等，故不能作为改变期别的根据）等，故不能作为改变期别的根据q对扫描检查怀疑的淋巴结行细针穿刺，能
10、帮助制定治疗计划对扫描检查怀疑的淋巴结行细针穿刺，能帮助制定治疗计划7/31/2024Dr.Xiaohua Wu 10宫颈癌分期:手术治疗后病理分期手术治疗后病理分期q手术手术-病理检查切除的标本结果，是最确切诊断肿瘤侵犯范围病理检查切除的标本结果，是最确切诊断肿瘤侵犯范围q这些结果不能改变临床分期，但可将这些结果记录在疾病的病理分这些结果不能改变临床分期，但可将这些结果记录在疾病的病理分期法则中，期法则中，TNM分期正是符合情况分期正是符合情况q首次诊断时确定分期，而且不能更改，即使在复发时也是如此首次诊断时确定分期，而且不能更改，即使在复发时也是如此q只有在临床分期的准则严格执行时，才有可
11、能比较各个临床单位和只有在临床分期的准则严格执行时，才有可能比较各个临床单位和不同治疗方式的结果不同治疗方式的结果7/31/2024Dr.Xiaohua Wu 117/31/2024Dr.Xiaohua Wu 12临床分期检查方法n临床分期临床分期q非损伤性诊断检查非损伤性诊断检查n双足淋巴管双足淋巴管X线照片（线照片（Bipedal lymphangiogram） n计算机断层计算机断层X线扫描术（线扫描术（CT, Computed Tomography） n超声波扫描术（超声波扫描术（Ultrasonography） n磁共振成像（磁共振成像（MRI, Magnetic Resonance
12、 Imaging） n正电子发射断层扫描（正电子发射断层扫描（PET, Positron Emission Tomography） n细针吸取细胞学检查细针吸取细胞学检查 q手术分期手术分期： 治疗前，腹主动脉旁治疗前，腹主动脉旁LN，延伸放射野，延伸放射野?n剖腹探查术的方法n腹腔镜分期7/31/2024Dr.Xiaohua Wu 13Surgical StagingnPretreatment surgical staging is the most accurate method to determine extent of disease. nBecause there is littl
13、e evidence to demonstrate overall improved survival with routine surgical staging, it usually should be performed only as part of a clinical trial. nPretreatment surgical staging in bulky, but locally curable, disease may be indicated in select cases when a nonsurgical search for metastatic disease
14、is negative. nIf abnormal nodes are detected by CT scan or lymphangiography, fine needle aspiration should be negative before a surgical staging procedure is performed. 7/31/2024Dr.Xiaohua Wu 14腹主动脉旁淋巴结腹主动脉旁淋巴结CT阴性患者中生存率曲线与阴性患者中生存率曲线与PET扫描结果的关系扫描结果的关系 J Clin Oncol 2001;19: 37453749.)7/31/2024Dr.Xiao
15、hua Wu 15IB期宫颈癌盆腔淋巴结转移率期宫颈癌盆腔淋巴结转移率 7/31/2024Dr.Xiaohua Wu 16 II 和和 III期宫颈癌腹主动脉旁淋巴结转移率期宫颈癌腹主动脉旁淋巴结转移率 7/31/2024Dr.Xiaohua Wu 17宫颈癌治疗：根据期别选择1.0期2.微小浸润癌3.B1期和早A癌4.B至至A期宫颈癌期宫颈癌7/31/2024Dr.Xiaohua Wu 18Stage 0 Cervical Cancer Standard treatment options: Methods to treat ectocervical lesions include: nLo
16、op electrosurgical excision procedure (LEEP).7,8 nLaser therapy.9 nConization. nCryotherapy.10 nWhen the endocervical canal is involved, laser or cold-knife conization may be used for selected patients to preserve the uterus and avoid radiation therapy and/or more extensive surgery. nTotal abdominal
17、 or vaginal hysterectomy is an accepted therapy for the postreproductive age group and is particularly indicated when the neoplastic process extends to the inner cone margin.nFor medically inoperable patients, a single intracavitary insertion with tandem and ovoids for 5,000 milligram hours (8,000 c
18、Gy vaginal surface dose) may be used.11 7/31/2024Dr.Xiaohua Wu 19对异常对异常Pap 涂片或活检示涂片或活检示微小浸润癌微小浸润癌处理步骤处理步骤 Pap涂片异常或钳取活检“微小浸润癌”锥切活检微小浸润5mml切缘阴性lECC阴性ECC阴性切缘和/或ECC示非典型增生lA1期l无广泛LVSIl如有生育愿望者锥切l筋膜外子宫切除再次锥切活检如锥切不便行改良RH盆腔淋巴结切除术l广泛LVSI的A1期lA2期l如有生育愿望者盆腔淋巴结切除加锥切，或广泛宫颈切除l改良RH和盆腔淋巴结切除7/31/2024Dr.Xiaohua Wu 20S
19、tage IA Cervical Cancer Equivalent treatment options: nIntracavitary radiation alone: nIf the depth of invasion is less than 3 millimeters and no capillary lymphatic space invasion is noted, the frequency of lymph node involvement is sufficiently low that external beam radiation is not required.n On
20、e or 2 insertions with tandem and ovoids for 6,500 to 8,000 milligram hours (10,000-12,500 cGy vaginal surface dose) are recommended.4 nRadiation should be reserved for women who are not surgical candidates. 7/31/2024Dr.Xiaohua Wu 21IB 和早和早 IIA期宫颈癌的治疗步骤期宫颈癌的治疗步骤l期l早期（阴道前壁侵犯）除外l根治性子宫切除l盆腔淋巴结切除l切除任何增大
21、腹主动脉旁淋巴结l淋巴结阴性l高危险（GOG分数120）多个阳性淋巴结或增大阳性淋巴结l淋巴结阴性l低危险观察小野盆腔放疗l延伸野放疗l顺铂周疗7/31/2024Dr.Xiaohua Wu 22Stage IIB Cervical Cancer Stage III Cervical Cancer Stage IVA Cervical Cancer Radiation therapy plus chemotherapy: Intracavitary radiation and external-beam pelvic irradiation combined with cisplatin or
22、cisplatin/fluorouracil.7-12 7/31/2024Dr.Xiaohua Wu 23晚期宫颈癌的诊治步骤B-A宫颈癌腹、盆腔CT盆、腹腔阴性l盆腔或腹腔淋巴结1.5cml附件包块胸部CT胸部CT阴性胸部CT阳性l切除附件包块l肿大淋巴结腹膜外切除l延伸野放疗和DDP周疗姑息性盆腔放疗预防性延伸野放疗和DDP周疗7/31/2024Dr.Xiaohua Wu 24Recurrent Cervical Cancer nStandard treatment options: nFor recurrence in the pelvis following radical surge
23、ry, radiation in combination with chemotherapy (fluorouracil with or without mitomycin) may cure 40% to 50% of patients.3 nChemotherapy can be used for palliation. Tested drugs include: qCisplatin (15%-25% response rate).4 qIfosfamide (15%-30% response rate).5,6 qIfosfamide-cisplatin.7,8 qPaclitaxel
24、 (17% response rate).9 qIrinotecan (21% response rate in patients previously treated with chemotherapy).10 qPaclitaxel/cisplatin (46% response rate).11 qCisplatin/gemcitabine (41% response rate).12 7/31/2024Dr.Xiaohua Wu 25术后放射治疗：术后放射治疗：范围及适应症范围及适应症n 标准野标准野 ：1.阳性盆腔淋巴结阳性阳性盆腔淋巴结阳性2.宫旁组织阳性宫旁组织阳性3.手术切缘阳
25、性患者手术切缘阳性患者n小野：淋巴结阴性小野：淋巴结阴性+高危因素高危因素1.临床肿瘤大小临床肿瘤大小2.淋巴管腔侵犯淋巴管腔侵犯3.肿瘤浸润深度肿瘤浸润深度7/31/2024Dr.Xiaohua Wu 26宫颈癌根治子宫和双侧盆腔淋巴结切除后无病生存率宫颈癌根治子宫和双侧盆腔淋巴结切除后无病生存率 7/31/2024Dr.Xiaohua Wu 27盆腔放射的标准野和小野之间的比较盆腔放射的标准野和小野之间的比较 7/31/2024Dr.Xiaohua Wu 287/31/2024Dr.Xiaohua Wu 297/31/2024Dr.Xiaohua Wu 307/31/2024Dr.Xiaohua Wu 317/31/2024Dr.Xiaohua Wu 327/31/2024Dr.Xiaohua Wu 337/31/2024Dr.Xiaohua Wu 34谢谢 谢谢
